DrugDashboards

Dexamethasone Sodium Phosphate

Dexamethasone Sodium Phosphate · DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL · Injection · Intra-Articular; Intralesional; Intramuscular; Intravenous; Soft Tissue · Somerset Therapeutics, LLC

NDC 70069-0023-25 · 25 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now. One of its named manufacturing plants, Somerset Therapeutics Private Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for dexamethasone sodium phosphate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $14.09 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA207521
TE code
AP
Approval date
Jun 8, 2018
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dexamethasone Sodium Phosphate (Injection)

LabelerStrengthFirst seenLast seen
Asclemed Usa Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLAug 13, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCDEXAMETHASONE SODIUM PHOSPHATE 100 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXAMETHASONE SODIUM PHOSPHATE 100 mg/10mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCDEXAMETHASONE SODIUM PHOSPHATE 100 mg/10mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Aug 31, 2026
Medical Purchasing Solutions, LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Aug 31, 2026
Somerset Therapeutics, LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dexamethasone Sodium Phosphate — NDC 70069-0023-25," retrieved September 3, 2026, https://drugdashboards.com/drug/70069002325.

Free to cite with attribution — see how the data is put together.